BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24647802)

  • 1. Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study.
    Frontzek K; Fluri F; Siemerkus J; Müller B; Gass A; Christ-Crain M; Katan M
    PLoS One; 2014; 9(3):e92421. PubMed ID: 24647802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
    Schweizer J; Arnold M; König IR; Bicvic A; Westphal LP; Schütz V; Inauen C; Scherrer N; Luft A; Galovic M; Ferreira Atuesta C; Pokorny T; Arnold M; Fischer U; Bonati LH; De Marchis GM; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Sagris D; Foerch C; Spanaus K; von Eckardstein A; Katan M
    J Am Coll Cardiol; 2022 Apr; 79(14):1369-1381. PubMed ID: 35393018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
    Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M
    J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-regional pro atrial natriuretic peptide allows the accurate identification of patients with atrial fibrillation of short time of onset: a pilot study.
    Meune C; Vermillet A; Wahbi K; Guerin S; Aelion H; Weber S; Chenevier-Gobeaux C
    Clin Biochem; 2011 Nov; 44(16):1315-9. PubMed ID: 21871875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of newly diagnosed atrial fibrillation in cryptogenic stroke: a cohort study.
    Bugnicourt JM; Flament M; Guillaumont MP; Chillon JM; Leclercq C; Canaple S; Lamy C; Godefroy O
    Eur J Neurol; 2013 Oct; 20(10):1352-9. PubMed ID: 23121252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly diagnosed atrial fibrillation after acute ischemic stroke and transient ischemic attack: importance of immediate and prolonged continuous cardiac monitoring.
    Sposato LA; Klein FR; Jáuregui A; Ferrúa M; Klin P; Zamora R; Riccio PM; Rabinstein A
    J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):210-6. PubMed ID: 20727789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
    Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
    De Marchis GM; Schneider J; Weck A; Fluri F; Fladt J; Foerch C; Mueller B; Luft A; Christ-Crain M; Arnold M; Katan M
    Neurology; 2018 Feb; 90(6):e455-e465. PubMed ID: 29321236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR-proANP level predicts new onset atrial fibrillation in patients with acute myocardial infarction.
    Karolina I; Michał K; Marzenna Z
    Biomarkers; 2020 Nov; 25(7):573-577. PubMed ID: 32972251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-atrial natriuretic peptide and prediction of atrial fibrillation and stroke: The Malmö Preventive Project.
    Berntsson J; Smith JG; Nilsson PM; Hedblad B; Melander O; Engström G
    Eur J Prev Cardiol; 2017 May; 24(8):788-795. PubMed ID: 28195503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
    Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
    Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 15. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
    Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
    Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).
    Richards M; Di Somma S; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Clopton P; Filippatos GS; Anand I; Ng L; Daniels LB; Neath SX; Shah K; Christenson R; Hartmann O; Anker SD; Maisel A
    JACC Heart Fail; 2013 Jun; 1(3):192-9. PubMed ID: 24621869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-proANP measured at admission is associated with incident atrial fibrillation in STEMI patients.
    Wegener A; Modin D; Pedersen S; Lindberg S; Pareek M; Iversen K; Jespersen T; Gislason G; Biering-Sørensen T
    Heart Vessels; 2022 Nov; 37(11):1906-1913. PubMed ID: 35648185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation detected after acute ischemic stroke: evidence supporting the neurogenic hypothesis.
    González Toledo ME; Klein FR; Riccio PM; Cassará FP; Muñoz Giacomelli F; Racosta JM; Roberts ES; Sposato LA
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e486-91. PubMed ID: 23800494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insular cortex lesions, cardiac troponin, and detection of previously unknown atrial fibrillation in acute ischemic stroke: insights from the troponin elevation in acute ischemic stroke study.
    Scheitz JF; Erdur H; Haeusler KG; Audebert HJ; Roser M; Laufs U; Endres M; Nolte CH
    Stroke; 2015 May; 46(5):1196-201. PubMed ID: 25835563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.